Commentary to "Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease".
Mandal
Pravat K
PK
Pettegrew
Jay W
JW
D000544:Alzheimer Disease / Q000473:pathology* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D006801:Humans; D006863:Hydrogen-Ion Concentration; D020961:Lewy Body Disease / Q000473:pathology* / Q000503:physiopathology; D051379:Mice; D008822:Mice, Transgenic; D019906:Nuclear Magnetic Resonance, Biomolecular; D010300:Parkinson Disease / Q000473:pathology* / Q000503:physiopathology; D010446:Peptide Fragments / Q000235:genetics / Q000378:metabolism; D051844:alpha-Synuclein / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D051844:alpha-Synuclein